ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1573

Health-related quality of life over 15 years in systemic sclerosis: impact of sex and survival

Katherine van der Wouden1, Georgy Gomon2, Rachel Knevel2, Michel Tsang-A-Sjoe3, Alexandre Voskuijl3 and Jeska de Vries-Bouwstra2, 1Leiden University Medical Center and Amsterdam University Medical Center, Leiden, Zuid-Holland, Netherlands, 2Leiden University Medical Center, Leiden, Netherlands, 3Amsterdam University Medical Center, Amsterdam, Netherlands

Meeting: ACR Convergence 2025

Keywords: Biostatistics, Patient reported outcomes, quality of life, SF36, Systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: (1553–1591) Systemic Sclerosis & Related Disorders – Clinical Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Patients with systemic sclerosis (SSc) face an uncertain long‑term outlook; understanding how their health‑related quality of life (HRQoL) changes over time can help them anticipate and plan for future challenges. For clinicians treating these patients, identifying which domains of HRQoL are most severely impacted and how they evolve over time can help facilitate more targeted and timely interventions aimed at improving patient outcomes. Given that males and females exhibit differences in disease activity and mortality related to SSc, this study aims to explore long-term HRQoL patterns stratified by sex, using the 36 Item Short Form Survey (SF-36).

Methods: Longitudinal data from 786 patients in the Leiden SSc cohort were analyzed using linear mixed models (LMMs) to assess changes in physical (PCS) and mental (MCS) component scores over time, with higher scores indicating better health, accounting for repeated measures. Cubic splines with knots at 2, 5, 7, and 10 years were included, with age, sex, and smoking status at baseline as fixed effects. A joint LMM explored trajectories across all SF-36 domains and their correlated random effects. Additionally, a Kaplan-Meier curve and a Cox model with a landmarking approach were used to assess sex-specific survival and the impact of PCS and MCS on all-cause mortality.

Results: Data from 3609 visits was used, with visits ranging from baseline to 15 years of follow-up, and a median follow-up time of 3 years. Mean age at baseline was 56 years, 77% (n=611) was female, and median disease duration (time since first non-Raynaud’s manifestation) at baseline was 2 years. At 15 years of follow-up, the estimated probability of death was 38.5% for males and 27.6% for females. Both the PCS and MCS remained essentially stable over 15 years for both males and females (Fig 1). Ever‑smokers had a lower PCS (-2.26, SE 0.72, p = 0.007). Older age predicted a faster PCS decline (p < 0.014).Males had a significantly higher MCS (2.53, SE 1.04, p=0.015), and MCS rose slightly with age (0.11, SE 0.03, p < 0.001). Older patients had a greater decline during the later stage of follow-up (between 7 and 10 years) (-0.22, SE 0.10, p=0.026). No significant sex differences in the MCS trajectory over time were observed.All eight domains showed stable scores (Fig 2A) and were strongly intercorrelated (Fig 2B).In the survival analysis, older age (HR 1.07, SE 0.01, p < 0.001) and male sex (HR 2.12, SE 0.14, p=0.022) increased death risk (Fig 3). Lastly, lower PCS were associated with higher mortality, with each 1-point lower PCS being linked to a 5% higher hazard of death (HR 0.95, SE 0.01, p < 0.001).

Conclusion: This 15‑year analysis—the longest SSc HRQoL follow‑up to date—shows a stable course of HRQoL in SSc over time as measured by the SF-36. Both the physical and mental component scores, and the different domains remain stable over time, with the domains showing high interconnectedness. Despite higher mortality, mental scores are better in male patients. Because worse self-reported physical health, older age, and male sex predict death, patients with low physical HRQoL scores warrant especially close monitoring and timely intervention.

Supporting image 1Fig 1. (A) Marginal PCS scores and (B) Marginal MCS scores over time for an average SSc patient stratified by sex. MCS: mental component score; PCS: physical component score; SSc: systemic sclerosis.

Supporting image 2Fig 2. (A) Marginal score of all eight domains over time for an average SSc patient. (B) Correlation table for each domain of the SF-36. BP: bodily pain; GH: general health; MH: mental health; PF: physical functioning; RE: role limitations due to emotional problems; RP: role limitations due to physical health; SF: social functioning; VT: vitality SSc: systemic sclerosis.

Supporting image 3Fig 3. Kaplan Meier plot for all-cause mortality with 95% confidence interval, stratified by sex.


Disclosures: K. van der Wouden: None; G. Gomon: None; R. Knevel: None; M. Tsang-A-Sjoe: None; A. Voskuijl: None; J. de Vries-Bouwstra: AbbVie/Abbott, 2, 6, Boehringer-Ingelheim, 2, 6, Jannsen-Cilag, 5, Janssen, 2, 6, Roche, 5.

To cite this abstract in AMA style:

van der Wouden K, Gomon G, Knevel R, Tsang-A-Sjoe M, Voskuijl A, de Vries-Bouwstra J. Health-related quality of life over 15 years in systemic sclerosis: impact of sex and survival [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/health-related-quality-of-life-over-15-years-in-systemic-sclerosis-impact-of-sex-and-survival/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/health-related-quality-of-life-over-15-years-in-systemic-sclerosis-impact-of-sex-and-survival/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology